Eaton Vance Management’s Hologic HOLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $5.33M | Buy |
82,691
+773
| +0.9% | +$53.5K | 0.01% | 762 |
|
|
2022
Q2 | $5.68M | Sell |
81,918
-51,252
| -38% | -$3.8M | 0.01% | 773 |
|
|
2022
Q1 | $10.2M | Buy |
133,170
+104,035
| +357% | +$7.48M | 0.01% | 684 |
|
|
2021
Q4 | $2.23M | Sell |
29,135
-193
| -0.7% | -$14.2K | ﹤0.01% | 1000 |
|
|
2021
Q3 | $1.78M | Sell |
29,328
-462
| -2% | -$34.6K | ﹤0.01% | 960 |
|
|
2021
Q2 | $1.99M | Buy |
29,790
+5,032
| +20% | +$336K | ﹤0.01% | 1015 |
|
|
2021
Q1 | $1.84M | Buy |
24,758
+956
| +4% | +$72.6K | ﹤0.01% | 996 |
|
|
2020
Q4 | $1.73M | Buy |
23,802
+509
| +2% | +$35.9K | ﹤0.01% | 956 |
|
|
2020
Q3 | $1.55M | Buy |
23,293
+732
| +3% | +$46.3K | ﹤0.01% | 902 |
|
|
2020
Q2 | $1.29M | Buy |
22,561
+299
| +1% | +$14.7K | ﹤0.01% | 908 |
|
|
2020
Q1 | $781K | Sell |
22,262
-145,524
| -87% | -$6.93M | ﹤0.01% | 973 |
|
|
2019
Q4 | $8.76M | Sell |
167,786
-27,870
| -14% | -$1.39M | 0.02% | 481 |
|
|
2019
Q3 | $9.88M | Sell |
195,656
-2,236
| -1% | -$110K | 0.02% | 443 |
|
|
2019
Q2 | $9.5M | Sell |
197,892
-936
| -0.5% | -$43.3K | 0.02% | 443 |
|
|
2019
Q1 | $9.62M | Sell |
198,828
-666
| -0.3% | -$30K | 0.02% | 419 |
|
|
2018
Q4 | $8.2M | Sell |
199,494
-424
| -0.2% | -$17.4K | 0.02% | 412 |
|
|
2018
Q3 | $8.19M | Sell |
199,918
-17,836
| -8% | -$721K | 0.02% | 452 |
|
|
2018
Q2 | $8.66M | Sell |
217,754
-265,872
| -55% | -$10.2M | 0.02% | 424 |
|
|
2018
Q1 | $18.1M | Buy |
483,626
+39,526
| +9% | +$1.6M | 0.02% | 404 |
|
|
2017
Q4 | $19M | Sell |
444,100
-92,289
| -17% | -$3.68M | 0.05% | 283 |
|
|
2017
Q3 | $19.7M | Sell |
536,389
-443,465
| -45% | -$17.9M | 0.05% | 260 |
|
|
2017
Q2 | $44.5M | Sell |
979,854
-205,892
| -17% | -$9.09M | 0.12% | 172 |
|
|
2017
Q1 | $50.5M | Buy |
1,185,746
+714,764
| +152% | +$29.1M | 0.14% | 158 |
|
|
2016
Q4 | $18.9M | Buy |
470,982
+302,476
| +180% | +$11.7M | 0.05% | 235 |
|
|
2016
Q3 | $6.54M | Buy |
168,506
+1,034
| +0.6% | +$39K | 0.02% | 367 |
|
|
2016
Q2 | $5.79M | Sell |
167,472
-14,532
| -8% | -$503K | 0.02% | 391 |
|
|
2016
Q1 | $6.28M | Buy |
182,004
+10,367
| +6% | +$362K | 0.02% | 363 |
|
|
2015
Q4 | $6.64M | Buy |
171,637
+14,993
| +10% | +$583K | 0.02% | 361 |
|
|
2015
Q3 | $6.13M | Buy |
156,644
+22,644
| +17% | +$898K | 0.02% | 376 |
|
|
2015
Q2 | $5.1M | Sell |
134,000
-25,000
| -16% | -$875K | 0.02% | 389 |
|
|
2015
Q1 | $5.25M | Buy |
159,000
+30,000
| +23% | +$921K | 0.02% | 398 |
|
|
2014
Q4 | $3.45M | Hold |
129,000
| – | – | 0.01% | 468 |
|
|
2014
Q3 | $3.14M | Sell |
129,000
-40,000
| -24% | -$1.01M | 0.01% | 460 |
|
|
2014
Q2 | $4.29M | Buy |
169,000
+40,000
| +31% | +$935K | 0.01% | 411 |
|
|
2014
Q1 | $2.77M | Hold |
129,000
| – | – | 0.01% | 471 |
|
|
2013
Q4 | $2.88M | Buy |
129,000
+100,000
| +345% | +$2.2M | 0.01% | 467 |
|
|
2013
Q3 | $599K | Hold |
29,000
| – | – | ﹤0.01% | 683 |
|
|
2013
Q2 | $560K | Buy |
+29,000
| New | +$606K | ﹤0.01% | 685 |
|
Other funds holding HOLX
Eaton Vance Management's HOLX Position: Q3 2022 in Review
Eaton Vance Management increased its Hologic (HOLX) stake by 0.94% in Q3 2022, buying an estimated $53.5K and bringing the position to 82,691 shares worth $5.33M. The position accounts for 0.01% of the portfolio, ranked #762.
Eaton Vance Management first reported a position in HOLX in Q2 2013 and has held it in 38 quarters since. The position peaked at $50.5M in Q1 2017. 654 funds tracked by Wall St. Rank hold HOLX as of Q3 2022.
- Eaton Vance Management held 82,691 shares of Hologic worth $5.33M as of Q3 2022.
- Eaton Vance Management bought 773 Hologic shares in Q3 2022, an estimated $53.5K.
- Hologic made up 0.01% of Eaton Vance Management's portfolio in Q3 2022, its #762 holding.
- Eaton Vance Management first reported a position in Hologic in Q2 2013 and has held it in 38 quarters since.
- Eaton Vance Management's Hologic position peaked at $50.5M in Q1 2017.
- 654 funds tracked by Wall St. Rank held Hologic as of Q3 2022.
Based on Eaton Vance Management's 13F filing for Q3 2022, filed 14 Nov 2022.